ELI LILLY AND COMPANY
Eli Lilly and Company is one of the
world's largest research-based pharmaceutical companies,
dedicated to creating and delivering innovative
pharmaceutical healthcare solutions that enable people to
live longer, healthier and more active lives. Our R&D efforts
constantly strive to address urgent unmet medical needs.
Eli Lilly and Company was founded in 1876 in
Indianapolis, USA, and has had a long history of producing
endocrine products, dating all the way back to the
collaboration with Banting and Best and the ntroduction of
the world's first insulin product in 1922.
Another element of Lilly's endocrine portfolio is GH
replacement. Lilly manufactures recombinant human GH
(somatropin) at Speke near Liverpool, UK. A full range of
products and services is provided for the healthcare
professional to use with their patients on GH replacement
therapy for both adults and children.
To assist in the therapeutic management of osteoporosis,
Lilly has two products, each catering for different patient
needs: Raloxifene and Teriparatide.
Finally, Lilly continues to focus significant resources on
research into the endocrine area. For additional information
about any of our endocrine products or services please log
on to the Lilly website: www.lilly.co.uk.
Eli Lilly and Company Ltd, Lilly House, Priestley Road,Basingstoke RG24 9NL, UK
Tel: 01256-315000
http://www.lilly.co.uk